Clinical evaluation

CS Carla Serra
FR Fernando Rizzello
CP Chiara Pratico’
CF Cristina Felicani
EF Erica Fiorini
RB Ramona Brugnera
EM Elena Mazzotta
FG Francesca Giunchi
MF Michelangelo Fiorentino
AD Antonietta D’Errico
AM Antonio Maria Morselli-Labate
MM Marianna Mastroroberto
MC Massimo Campieri
GP Gilberto Poggioli
PG Paolo Gionchetti
ask Ask a question
Favorite

Clinical activity at the time of US examination was assessed using the HBI (clinical remission, HBI ≤ 4; mild disease activity, 5 ≤ HBI ≤ 7; moderate–severe disease activity, HBI ≥ 8) while CRP was used as the biochemical activity marker (positive if > 0.8 mg/dl). For statistical analysis, patients were dichotomized in mild (HBI ≤ 7) and moderate–severe activity (HBI ≥ 8).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A